XML 50 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value of Financial Instruments (Tables)
6 Months Ended
Jun. 30, 2013
Fair Value Disclosures [Abstract]  
Fair Value Hierarchy Tables Present Information about Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following fair value hierarchy table presents information about our assets and liabilities that are measured at fair value on a recurring basis as of June 30, 2013:
(Dollars in thousands)
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Balance at June 30, 2013
Assets
 
 
 
 
 
 
 
 
Available-for-sale securities:
 
 
 
 
 
 
 
 
U.S. treasury securities
 
$
—

 
$
24,999

 
$
—

 
$
24,999

U.S. agency debentures
 
—

 
3,403,589

 
—

 
3,403,589

Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
Agency-issued mortgage-backed securities
 
—

 
1,214,035

 
—

 
1,214,035

Agency-issued collateralized mortgage obligations - fixed rate
 
—

 
3,468,682

 
—

 
3,468,682

Agency-issued collateralized mortgage obligations - variable rate
 
—

 
1,438,772

 
—

 
1,438,772

Agency-issued commercial mortgage-backed securities
 
—

 
401,204

 
—

 
401,204

Municipal bonds and notes
 
—

 
87,001

 
—

 
87,001

Equity securities
 
1,049

 
4,010

 
—

 
5,059

Total available-for-sale securities
 
1,049

 
10,042,292

 
—

 
10,043,341

Non-marketable securities (fair value accounting):
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments
 
—

 
—

 
741,522

 
741,522

Other venture capital investments
 
—

 
—

 
123,493

 
123,493

Total non-marketable securities (fair value accounting)
 
—

 
—

 
865,015

 
865,015

Other assets:
 
 
 
 
 
 
 
 
Marketable securities
 
9,063

 
—

 
—

 
9,063

Interest rate swaps
 
—

 
7,224

 
—

 
7,224

Foreign exchange forward and option contracts
 
—

 
16,395

 
—

 
16,395

Equity warrant assets
 
—

 
3,355

 
73,229

 
76,584

Loan conversion options
 
—

 
1,595

 
—

 
1,595

Client interest rate derivatives
 
—

 
136

 
—

 
136

Total assets (1)
 
$
10,112

 
$
10,070,997

 
$
938,244

 
$
11,019,353

Liabilities
 
 
 
 
 
 
 
 
Foreign exchange forward and option contracts
 
$
—

 
$
11,298

 
$
—

 
$
11,298

Client interest rate derivatives
 
—

 
145

 
—

 
145

Total liabilities
 
$
—

 
$
11,443

 
$
—

 
$
11,443

 
 
(1)
Included in Level 1 and Level 3 assets are $8.6 million and $778 million, respectively, attributable to noncontrolling interests calculated based on the ownership percentages of the noncontrolling interests.
The following fair value hierarchy table presents information about our assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2012:
(Dollars in thousands)
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Balance at December 31, 2012
Assets
 
 
 
 
 
 
 
 
Available-for-sale securities:
 
 
 
 
 
 
 
 
U.S. treasury securities
 
$
—

 
$
25,247

 
$
—

 
$
25,247

U.S. agency debentures
 
—

 
3,447,628

 
—

 
3,447,628

Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
Agency-issued mortgage-backed securities
 
—

 
1,473,433

 
—

 
1,473,433

Agency-issued collateralized mortgage obligations - fixed rate
 
—

 
4,103,974

 
—

 
4,103,974

Agency-issued collateralized mortgage obligations - variable rate
 
—

 
1,772,748

 
—

 
1,772,748

Agency-issued commercial mortgage-backed securities
 
—

 
422,098

 
—

 
422,098

Municipal bonds and notes
 
—

 
93,529

 
—

 
93,529

Equity securities
 
4,520

 
—

 
—

 
4,520

Total available-for-sale securities
 
4,520

 
11,338,657

 
—

 
11,343,177

Non-marketable securities (fair value accounting):
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments
 
—

 
—

 
665,921

 
665,921

Other venture capital investments
 
—

 
—

 
127,091

 
127,091

Total non-marketable securities (fair value accounting)
 
—

 
—

 
793,012

 
793,012

Other assets:
 
 
 
 
 
 
 
 
Marketable securities
 
1,144

 
9,184

 
—

 
10,328

Interest rate swaps
 
—

 
9,005

 
—

 
9,005

Foreign exchange forward and option contracts
 
—

 
13,541

 
—

 
13,541

Equity warrant assets
 
—

 
8,143

 
66,129

 
74,272

Loan conversion options
 
—

 
890

 
—

 
890

Client interest rate derivatives
 
—

 
558

 
—

 
558

Total assets (1)
 
$
5,664

 
$
11,379,978

 
$
859,141

 
$
12,244,783

Liabilities
 
 
 
 
 
 
 
 
Foreign exchange forward and option contracts
 
$
—

 
$
12,847

 
$
—

 
$
12,847

Client interest rate derivatives
 
—

 
590

 
—

 
590

Total liabilities
 
$
—

 
$
13,437

 
$
—

 
$
13,437

 
 
(1)
Included in Level 1, Level 2, and Level 3 assets are $1.1 million, $8.7 million, and $708 million, respectively, attributable to noncontrolling interests calculated based on the ownership percentages of the noncontrolling interests.

Additional Information about Level 3 Assets Measured at Fair Value on a Recurring Basis
The following table presents additional information about Level 3 assets measured at fair value on a recurring basis for the three and six months ended June 30, 2013 and 2012, respectively:
(Dollars in thousands)
 
Beginning
Balance
 
Total Realized and Unrealized Gains (Losses) Included in Income
 
Purchases  
 
Sales
 
Issuances  
 
Distributions and Other Settlements
 
Transfers Into Level 3 
 
Transfers Out of Level 3
 
Ending
Balance
Three months ended June 30, 2013
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-marketable securities (fair value accounting):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments
 
$
701,076

 
$
33,728

 
$
35,574

 
$
—

 
$
—

 
$
(28,856
)
 
$
—

 
$
—

 
$
741,522

Other venture capital investments
 
124,786

 
(939
)
 
28

 
(364
)
 
—

 
(18
)
 
—

 
—

 
123,493

Total non-marketable securities (fair value accounting) (1)
 
825,862

 
32,789

 
35,602

 
(364
)
 
—

 
(28,874
)
 
—

 
—

 
865,015

Other assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity warrant assets (2)
 
66,046

 
6,468

 
—

 
(2,189
)
 
2,388

 
1,014

 
—

 
(498
)
 
73,229

Total assets
 
$
891,908

 
$
39,257

 
$
35,602

 
$
(2,553
)
 
$
2,388

 
$
(27,860
)
 
$
—

 
$
(498
)
 
$
938,244

Three months ended June 30, 2012
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-marketable securities (fair value accounting):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments
 
$
620,356

 
$
14,557

 
$
33,365

 
$
—

 
$
—

 
$
(28,682
)
 
$
—

 
$
—

 
$
639,596

Other venture capital investments
 
127,951

 
(3,540
)
 
211

 
(3,932
)
 
—

 
16

 
—

 
(595
)
 
120,111

Other investments
 
1,002

 
—

 
—

 
—

 
—

 
(1,002
)
 
—

 
—

 
—

Total non-marketable securities (fair value accounting) (1)
 
749,309

 
11,017

 
33,576

 
(3,932
)
 
—

 
(29,668
)
 
—

 
(595
)
 
759,707

Other assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity warrant assets (2)
 
65,217

 
5,853

 
—

 
(6,075
)
 
3,873

 
—

 
—

 
(249
)
 
68,619

Total assets
 
$
814,526

 
$
16,870

 
$
33,576

 
$
(10,007
)
 
$
3,873

 
$
(29,668
)
 
$
—

 
$
(844
)
 
$
828,326

Six months ended June 30, 2013
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-marketable securities (fair value accounting):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments
 
$
665,921

 
$
56,238

 
$
65,318

 
$
—

 
$
—

 
$
(45,955
)
 
$
—

 
$
—

 
$
741,522

Other venture capital investments
 
127,091

 
1,249

 
194

 
(385
)
 
—

 
(1,095
)
 
—

 
(3,561
)
 
123,493

Total non-marketable securities (fair value accounting) (1)
 
793,012

 
57,487

 
65,512

 
(385
)
 
—

 
(47,050
)
 
—

 
(3,561
)
 
865,015

Other assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity warrant assets (2)
 
66,129

 
7,927

 
—

 
(4,439
)
 
4,314

 
1,378

 
—

 
(2,080
)
 
73,229

Total assets
 
$
859,141

 
$
65,414

 
$
65,512

 
$
(4,824
)
 
$
4,314

 
$
(45,672
)
 
$
—

 
$
(5,641
)
 
$
938,244

Six months ended June 30, 2012
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-marketable securities (fair value accounting):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments
 
$
611,824

 
$
26,661

 
$
55,081

 
$
—

 
$
—

 
$
(53,970
)
 
$
—

 
$
—

 
$
639,596

Other venture capital investments
 
124,121

 
(7,127
)
 
7,935

 
(4,239
)
 
—

 
16

 
—

 
(595
)
 
120,111

Other investments
 
987

 
21

 
—

 
—

 
—

 
(1,008
)
 
—

 
—

 
—

Total non-marketable securities (fair value accounting) (1)
 
736,932

 
19,555

 
63,016

 
(4,239
)
 
—

 
(54,962
)
 
—

 
(595
)
 
759,707

Other assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity warrant assets (2)
 
63,030

 
9,648

 
—

 
(9,718
)
 
6,173

 
1

 
—

 
(515
)
 
68,619

Total assets
 
$
799,962

 
$
29,203

 
$
63,016

 
$
(13,957
)
 
$
6,173

 
$
(54,961
)
 
$
—

 
$
(1,110
)
 
$
828,326

 
 
(1)
Realized and unrealized gains (losses) are recorded on the line items “gains on investment securities, net”, and “other noninterest income”, components of noninterest income.
(2)
Realized and unrealized gains (losses) are recorded on the line item “gains on derivative instruments, net”, a component of noninterest income.
Unrealized Gains Included in Earnings Attributable to Level 3 Assets Held
The following table presents the amount of unrealized gains (losses) included in earnings (which is inclusive of noncontrolling interest) attributable to Level 3 assets still held at June 30, 2013:
 
 
Three months ended June 30,
 
Six months ended June 30,
(Dollars in thousands)
 
2013
 
2012
 
2013
 
2012
Non-marketable securities (fair value accounting):
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments
 
$
34,390

 
$
14,543

 
$
57,011

 
$
26,192

Other venture capital investments
 
(209
)
 
10,819

 
1,117

 
8,208

Other investments
 
—

 
—

 
—

 
21

Total non-marketable securities (fair value accounting) (1)
 
34,181

 
25,362

 
58,128

 
34,421

Other assets:
 
 
 
 
 
 
 
 
Equity warrant assets (2)
 
5,240

 
2,888

 
6,279

 
3,392

Total unrealized gains
 
$
39,421

 
$
28,250

 
$
64,407

 
$
37,813

Unrealized gains attributable to noncontrolling interests
 
$
28,482

 
$
21,721

 
$
50,245

 
$
28,969

 

(1)
Unrealized gains (losses) are recorded on the line items “gains on investment securities, net”, and “other noninterest income”, components of noninterest income.
(2)
Unrealized gains (losses) are recorded on the line item “gains on derivative instruments, net”, a component of noninterest income.
Quantitative Information About Significant Unobservable Inputs
The following table presents quantitative information about the significant unobservable inputs used for certain of our Level 3 fair value measurements at June 30, 2013. We have not included in this table our venture capital and private equity fund investments (fair value accounting) as we use net asset value per share (as obtained from the general partners of the investments) as a practical expedient to determine fair value.
(Dollars in thousands)
 
Fair value
 
Valuation Technique
 
Significant Unobservable Inputs
 
Weighted 
Average
June 30, 2013:
 
 
 
 
 
 
 
 
Other venture capital investments (fair value accounting)
 
$
123,493

 
Private company equity pricing
 
(1)
 
(1
)
Equity warrant assets (private portfolio)
 
73,229

 
Modifed Black-Scholes option pricing model
 
Volatility
 
40.6
%
 
 
 
 
 
Risk-Free interest rate
 
0.7
%
 
 
 
 
 
Marketability discount (2)
 
22.5
%
 
 
 
 
 
Remaining life assumption (3)
 
45.0
%
December 31, 2012:
 
 
 
 
 
 
 
 
Other venture capital investments (fair value accounting)
 
127,091

 
Private company equity pricing
 
(1)
 
(1
)
Equity warrant assets (private portfolio)
 
66,129

 
Modifed Black-Scholes option pricing model
 
Volatility
 
45.2
%
 
 
 
 
 
Risk-Free interest rate
 
0.4
%
 
 
 
 
 
Marketability discount (2)
 
22.5
%
 
 
 
 
 
Remaining life assumption (3)
 
45.0
%
 
 
 
(1)
In determining the fair value of our other venture capital investment portfolio, we evaluate a variety of factors related to each underlying private portfolio company including, but not limited to, actual and forecasted results, cash position, recent or planned transactions and market comparable companies. Additionally, we have ongoing communication with the portfolio companies and venture capital fund managers, to determine whether there is a material change in fair value. These factors are specific to each portfolio company and a weighted average or range of values of the unobservable inputs is not meaningful.
(2)
Our marketability discount is applied to all private company warrants to account for a general lack of liquidity due to the private nature of the associated underlying company. The quantitative measure used is based on long-run averages and is influenced over time by various factors, including market conditions. On a quarterly basis, a sensitivity analysis is performed on our marketability discount.
(3)
We adjust the contractual remaining term of private company warrants based on our estimate of the actual remaining life, which we determine by utilizing historical data on cancellations and exercises. At June 30, 2013, the weighted average contractual remaining term was 6.4 years, compared to our estimated remaining life of 2.9 years. On a quarterly basis, a sensitivity analysis is performed on our remaining life assumption.
Summary of Estimated Fair Values of Financial Instruments Not Carried at Fair Value
The following fair value hierarchy table presents the estimated fair values of our financial instruments that are not carried at fair value at June 30, 2013 and December 31, 2012:
 
 
 
 
Estimated Fair Value
(Dollars in thousands)
 
Carrying Amount
 
Quoted Prices in Active Markets for Identical Assets
(Level 1)
 
Significant Other Observable Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
June 30, 2013:
 
 
 
 
 
 
 
 
Financial assets:
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
873,251

 
$
873,251

 
$
—

 
$
—

Non-marketable securities (cost and equity method accounting)
 
390,410

 
—

 
—

 
440,085

Net commercial loans
 
8,643,961

 
—

 
—

 
8,794,118

Net consumer loans
 
858,640

 
—

 
—

 
890,101

FHLB and Federal Reserve Bank stock
 
40,532

 
—

 
—

 
40,532

Accrued interest receivable
 
68,571

 
—

 
68,571

 
—

Financial liabilities:
 
 
 
 
 
 
 
 
Other short-term borrowings
 
5,400

 
5,400

 
—

 
—

Non-maturity deposits (1)
 
18,533,244

 
18,533,244

 
—

 
—

Time deposits
 
156,830

 
—

 
156,884

 
—

5.375% Senior Notes
 
348,101

 
—

 
383,684

 
—

6.05% Subordinated Notes (2)
 
52,728

 
—

 
57,559

 
—

7.0% Junior Subordinated Debentures
 
55,109

 
—

 
52,289

 
—

Accrued interest payable
 
6,586

 
—

 
6,586

 
—

Off-balance sheet financial assets:
 
 
 
 
 
 
 
 
Commitments to extend credit
 
—

 
—

 
—

 
22,090

December 31, 2012:
 
 
 
 
 
 
 
 
Financial assets:
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
1,008,983

 
$
1,008,983

 
$
—

 
$
—

Non-marketable securities (cost and equity method accounting)
 
391,253

 
—

 
—

 
425,741

Net commercial loans
 
8,013,563

 
—

 
—

 
8,180,597

Net consumer loans
 
822,719

 
—

 
—

 
860,772

FHLB and Federal Reserve Bank stock
 
39,806

 
—

 
—

 
39,806

Accrued interest receivable
 
64,167

 
—

 
64,167

 
—

Financial liabilities:
 
 
 
 
 
 
 
 
Federal funds purchased
 
160,000

 
160,000

 
—

 
—

Other short-term borrowings
 
6,110

 
6,110

 
—

 
—

Non-maturity deposits (1)
 
19,021,264

 
19,021,264

 
—

 
—

Time deposits
 
155,188

 
—

 
155,027

 
—

5.375% Senior Notes
 
347,995

 
—

 
393,701

 
—

6.05% Subordinated Notes (2)
 
54,571

 
—

 
61,639

 
—

7.0% Junior Subordinated Debentures
 
55,196

 
—

 
51,959

 
—

Accrued interest payable
 
6,494

 
—

 
6,494

 
—

Off-balance sheet financial assets:
 
 
 
 
 
 
 
 
Commitments to extend credit
 
—

 
—

 
—

 
20,562

 
 
(1)
Includes noninterest-bearing demand deposits, interest-bearing checking accounts, money market accounts and interest-bearing sweep deposits.
(2)
At June 30, 2013 and December 31, 2012, included in the carrying value and estimated fair value of our 6.05% Subordinated Notes was $7.2 million and $9.0 million, respectively, related to hedge accounting associated with the notes.
Summary of Estimated Fair Values of Investments and Remaining Unfunded Commitments for Each Major Category of Investments
The following table is a summary of the estimated fair values of these investments and remaining unfunded commitments for each major category of these investments as of June 30, 2013:
(Dollars in thousands)
 
Carrying Amount      
 
Fair Value        
 
Unfunded
Commitments      
Non-marketable securities (fair value accounting):
 
 
 
 
 
 
Venture capital and private equity fund investments (1)
 
$
741,522

 
$
741,522

 
$
433,083

Non-marketable securities (equity method accounting):
 
 
 
 
 
 
Other investments (2)
 
53,962

 
55,404

 
17,258

Non-marketable securities (cost method accounting):
 
 
 
 
 
 
Venture capital and private equity fund investments (3)
 
156,391

 
203,847

 
46,512

Total
 
$
951,875

 
$
1,000,773

 
$
496,853

 
 
(1)
Venture capital and private equity fund investments within non-marketable securities (fair value accounting) include investments made by our managed funds of funds and one of our direct venture funds. These investments represent investments in venture capital and private equity funds that invest primarily in U.S. and global technology and life sciences companies. Included in the fair value and unfunded commitments of fund investments under fair value accounting are $663 million and $425 million, respectively, attributable to noncontrolling interests. It is estimated that we will receive distributions from the fund investments over the next 10 to 13 years, depending on the age of the funds and any potential extensions of terms of the funds.
(2)
Other investments within non-marketable securities (equity method accounting) include investments in debt funds and venture capital and private equity fund investments that invest in or lend money to primarily U.S. and global technology and life sciences companies. It is estimated that we will receive distributions from the fund investments over the next 10 to 13 years, depending on the age of the funds.
(3)
Venture capital and private equity fund investments within non-marketable securities (cost method accounting) include investments in venture capital and private equity fund investments that invest primarily in U.S. and global technology and life sciences companies. It is estimated that we will receive distributions from the fund investments over the next 10 to 13 years, depending on the age of the funds and any potential extensions of the terms of the funds.